Publications by authors named "Neil Wintfeld"

Claim this Profile
P
Pregnancy snapshot: a retrospective, observational case-control study to evaluate the potential effects of maternal diabetes treatment during pregnancy on macrosomia.
Michael H Shannon, Neil Wintfeld, Michael Liang, Lois Jovanovic

Curr Med Res Opin· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.
Michael L Ganz, Qian Li, Neil S Wintfeld, Yuan-Chi Lee, Christopher Sorli

Curr Med Res Opin· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs.
Phil Schwab, Vishal Saundankar, Jonathan Bouchard, Neil Wintfeld, Brandon Suehs

BMJ Open Diabetes Res Care· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting error in weight and its implications for bias in economic models.
John Cawley, Johanna Catherine Maclean, Mette Hammer, Neil Wintfeld

Econ Hum Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy.
Lois Jovanovič, Yuanjie Liang, Wayne Weng, Marianthe Hamilton, Lisa Chen, Neil Wintfeld

Diabetes Metab Res Rev· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
John Cawley, Chad Meyerhoefer, Adam Biener, Mette Hammer, Neil Wintfeld

Pharmacoeconomics· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of lifestyle intervention to prevent diabetes and sequelae.
Timothy M Dall, Michael V Storm, April P Semilla, Neil Wintfeld, Michael O'Grady

Am J Prev Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes.
Timothy M Dall, Wenya Yang, Pragna Halder, Bo Pang, Marjan Massoudi, Neil Wintfeld

Diabetes Care· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States.
Michael L Ganz, Neil S Wintfeld, Qian Li, Yuan-Chi Lee, Elyse Gatt

Curr Med Res Opin· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogs.
Marco DiBonaventura, Neil Wintfeld, Joanna Huang, Amir Goren

Patient Prefer Adherence· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States.
Michael L Ganz, Neil Wintfeld, Qian Li, Veronica Alas, Jakob Langer

Diabetol Metab Syndr· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy.
Alexander Diamantopoulos, Maurizio Benucci, Stefano Capri, Wolfgang Berger, Neil Wintfeld

J Med Econ· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review.
Rudolf Weide, Hubert Koppler, Lucia Antras, Michael Smith, M P H Eva Chang, Neil Wintfeld

J Cancer Res Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs.
Gert J D Bergman, Marc C Hochberg, Maarten Boers, Neil Wintfeld, Adrian Kielhorn

Semin Arthritis Rheum· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
Ingo J Diel, Rudolf Weide, Hubert Köppler, Lucia Antràs, Michael Smith, Neil Wintfeld

Support Care Cancer· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a.
Patrick Marcellin, George K K Lau, Stefan Zeuzem, E Jenny Heathcote, Paul J Pockros, Neil Wintfeld

Liver Int· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United States.
John Hornberger, J Michael Kilby, Neil Wintfeld, Jesse Green

AIDS Res Hum Retroviruses· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life.
Sanjeev Arora, Christopher O'Brien, Stefan Zeuzem, Mitchell L Shiffman, Moises Diago, Neil Wintfeld

J Gastroenterol Hepatol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy.
John Hornberger, Jesse Green, Neil Wintfeld, Matthias Cavassini, Jürgen Rockstroh

HIV Clin Trials· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with enfuvirtide (ENF; T-20) in combination with an optimized background regimen.
Calvin J Cohen, Nathan Clumeck, Jean-Michel Molina, Melanie Thompson, Kavita Patel, Neil Wintfeld

J Acquir Immune Defic Syndr· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C.
Sean D Sullivan, Antonio Craxi, Alfredo Alberti, Giovanni Giuliani, Claudio De Carli, Neil Wintfeld

Pharmacoeconomics· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.
Tarek Hassanein, Graham Cooksley, Mark Sulkowski, Coleman Smith, George Marinos, Neil Wintfeld

J Hepatol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient acceptance of self-injected enfuvirtide at 8 and 24 weeks.
Calvin Cohen, James Hellinger, Margaret Johnson, Schlomo Staszewski, Neil Wintfeld

HIV Clin Trials· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.
Jens Rasenack, Stefan Zeuzem, S Victor Feinman, E Jenny Heathcote, Michael Manns, Neil Wintfeld

Pharmacoeconomics· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous injection survey: psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medication.
Jesse Green, Leah Kleinman, Gabrielle Ciesla, Joanna Huang, Neil Wintfeld

HIV Clin Trials· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis